Eurofins Competitors and Similar CompaniesClear all
Eurofins's competitors and similar companies include Vanda Pharmaceuticals.
 Vanda Pharmaceuticals Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. | ||
Founding Date | Founding Date 1987 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Washington, US HQ Berlin, DE London, GB | |
Employees | Employees 65,694 | Employees 2845% increase |
Valuation ($) | Valuation ($) 9.5 b | Valuation ($) 273.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) €7.3b (FY, 2025) | Revenue (est.) $216.1m (FY, 2025) |
Net income | Net income €473m (FY, 2025) | Net income ($220.5m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 54m |
For sources of this data, please see the company profile
View Company Profiles
Vanda Pharmaceuticals
HQ
Washington, US
Employees
284↑ 5% increase
Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.
View company